Assert-IQ vs Cleerly LABS
AI Verdict
Choose Assert-IQ if…
Choose Assert-IQ if your primary goal is long-term, continuous monitoring to diagnose elusive or infrequent cardiac arrhythmias. This tool is ideal for patients experiencing intermittent symptoms such as syncope, palpitations, or cryptogenic stroke where a suspected heart rhythm disorder requires prolonged observation beyond standard external monitors. It provides comprehensive arrhythmia detection over several years, enabling timely diagnosis and management.
View Assert-IQ →Choose Cleerly LABS if…
Choose Cleerly LABS if you need a detailed, AI-powered assessment of coronary artery disease based on CT angiography. This software is best suited for evaluating the presence, extent, and characteristics of atherosclerosis and stenosis in patients with known or suspected CAD. It provides critical insights for personalized risk assessment, guiding treatment strategies, and tracking disease progression over time.
View Cleerly LABS →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Assert-IQ | Cleerly LABS |
|---|---|---|
| Pricing | Enterprise | Per analysis |
| Deployment | Hybrid | Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer. |
| FDA Status | Cleared AI-estimated | 1 AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Cleerly LABSCleerly LABS offers a web-based application with 3D visualization and explicit integration with PACS, RIS, and EHR systems, providing a direct and interactive experience for clinicians analyzing imaging data. Assert-IQ, while offering remote monitoring and a patient app, primarily functions as a device-plus-platform, and the clinician interface for its cloud platform is not as explicitly detailed for interactive analysis.
Clinical Value
Cleerly LABSCleerly LABS provides a novel, AI-powered approach to cardiovascular disease management by offering comprehensive, quantitative analysis of coronary plaque beyond traditional stenosis, aiming to personalize heart attack prevention. Assert-IQ offers crucial long-term continuous cardiac monitoring for arrhythmia detection, which is an advancement in its field, but Cleerly's focus on detailed plaque characterization addresses a broader and potentially more impactful area of cardiovascular disease prevention.
Pricing & Value
Cleerly LABSCleerly LABS provides transparent per-analysis pricing, including retail and discounted rates, and mentions potential insurance coverage, allowing for clear cost assessment. Assert-IQ's pricing is opaque, listed as 'enterprise' and requiring direct contact with Abbott Medical for institutional pricing, which makes it difficult for potential customers to evaluate its value proposition upfront.
Enterprise Readiness
Assert-IQAbbott Medical, the company behind Assert-IQ, is a global healthcare leader founded in 1888, providing a highly established infrastructure, extensive experience, and a broad network for enterprise-level deployment and support. While Cleerly LABS offers robust cloud-based deployment and integration with PACS/RIS/EHR, Abbott's long-standing history and explicit targeting of large health systems give it a significant advantage in overall enterprise readiness.
Innovation
Cleerly LABSCleerly LABS offers a highly innovative, AI-driven solution that fundamentally changes how coronary artery disease is assessed by quantifying and characterizing plaque beyond simple stenosis, with the stated mission to eliminate heart attacks. Assert-IQ, while an advanced insertable cardiac monitor with extended monitoring capabilities and improved data transmission, represents an evolutionary improvement within an existing device category rather than a disruptive new approach.
Support & Docs
Assert-IQAbbott Medical, as a large and established global healthcare company, possesses a comprehensive and mature infrastructure for customer support, technical documentation, and professional resources for its products. While Cleerly offers client support and resources, the extensive scale and long-standing presence of Abbott suggest a more robust and readily available support ecosystem for enterprise clients.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Assert-IQ | Cleerly LABS |
|---|---|---|
| Name | Assert-IQ | Cleerly LABS |
| Company | Abbott Medical | Cleerly |
| Primary Function | Long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders. | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. |
| Key Feature (Monitoring/Analysis) | Long-term continuous cardiac monitoring (up to 6 years) with advanced arrhythmia detection algorithms. | AI-powered CCTA image analysis for comprehensive coronary plaque assessment (volume, type) and stenosis detection and quantification. |
| Target Specialties/Categories | Cardiology, Internal Medicine | Cardiology AI, Radiology & Imaging AI |
| Data Export/Integration | yes (data export) | Integration with PACS, RIS, EHR via Cleerly Proxy |
Videos
Demos, reviews, and walkthroughs featuring Assert-IQ and Cleerly LABS.
Frequently Asked Questions
More Comparisons
More matchups featuring Assert-IQ or Cleerly LABS
Backers
Who funded each tool's parent company.